3CAR

B7-H3-targeted autologous CAR-T cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3CAR, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) [Phase 1]

See pricing